BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

979 related articles for article (PubMed ID: 11375494)

  • 1. Impairment of the ubiquitin-proteasome system by protein aggregation.
    Bence NF; Sampat RM; Kopito RR
    Science; 2001 May; 292(5521):1552-5. PubMed ID: 11375494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation.
    Waelter S; Boeddrich A; Lurz R; Scherzinger E; Lueder G; Lehrach H; Wanker EE
    Mol Biol Cell; 2001 May; 12(5):1393-407. PubMed ID: 11359930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating huntingtin half-life alters polyglutamine-dependent aggregate formation and cell toxicity.
    Kaytor MD; Wilkinson KD; Warren ST
    J Neurochem; 2004 May; 89(4):962-73. PubMed ID: 15140195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells.
    Dantuma NP; Lindsten K; Glas R; Jellne M; Masucci MG
    Nat Biotechnol; 2000 May; 18(5):538-43. PubMed ID: 10802622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell biology. Protein clumps hijack cell's clearance system.
    Helmuth L
    Science; 2001 May; 292(5521):1467-8. PubMed ID: 11379612
    [No Abstract]   [Full Text] [Related]  

  • 6. Synphilin-1 degradation by the ubiquitin-proteasome pathway and effects on cell survival.
    Lee G; Junn E; Tanaka M; Kim YM; Mouradian MM
    J Neurochem; 2002 Oct; 83(2):346-52. PubMed ID: 12423244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.
    Chai Y; Koppenhafer SL; Shoesmith SJ; Perez MK; Paulson HL
    Hum Mol Genet; 1999 Apr; 8(4):673-82. PubMed ID: 10072437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the ubiquitin/proteasome system in sorting of the interleukin 2 receptor beta chain to late endocytic compartments.
    Rocca A; Lamaze C; Subtil A; Dautry-Varsat A
    Mol Biol Cell; 2001 May; 12(5):1293-301. PubMed ID: 11359922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing.
    Jensen TJ; Loo MA; Pind S; Williams DB; Goldberg AL; Riordan JR
    Cell; 1995 Oct; 83(1):129-35. PubMed ID: 7553864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons.
    McLean PJ; Kawamata H; Hyman BT
    Neuroscience; 2001; 104(3):901-12. PubMed ID: 11440819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of CFTR by the ubiquitin-proteasome pathway.
    Ward CL; Omura S; Kopito RR
    Cell; 1995 Oct; 83(1):121-7. PubMed ID: 7553863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inefficient degradation of truncated polyglutamine proteins by the proteasome.
    Holmberg CI; Staniszewski KE; Mensah KN; Matouschek A; Morimoto RI
    EMBO J; 2004 Oct; 23(21):4307-18. PubMed ID: 15470501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A principal role for the proteasome in endoplasmic reticulum-associated degradation of misfolded intracellular cystic fibrosis transmembrane conductance regulator.
    Gelman MS; Kannegaard ES; Kopito RR
    J Biol Chem; 2002 Apr; 277(14):11709-14. PubMed ID: 11812794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: effects on replication, transcription, translation, and the cellular stress response.
    Mimnaugh EG; Chen HY; Davie JR; Celis JE; Neckers L
    Biochemistry; 1997 Nov; 36(47):14418-29. PubMed ID: 9398160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoproteolytic activity of the proteasome.
    Liu CW; Corboy MJ; DeMartino GN; Thomas PJ
    Science; 2003 Jan; 299(5605):408-11. PubMed ID: 12481023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol.
    Ma J; Lindquist S
    Science; 2002 Nov; 298(5599):1785-8. PubMed ID: 12386336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
    Zhang XM; Lin H; Chen C; Chen BD
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components.
    Stenoien DL; Mielke M; Mancini MA
    Nat Cell Biol; 2002 Oct; 4(10):806-10. PubMed ID: 12360291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release.
    Jana NR; Zemskov EA; Wang Gh ; Nukina N
    Hum Mol Genet; 2001 May; 10(10):1049-59. PubMed ID: 11331615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggregate formation inhibits proteasomal degradation of polyglutamine proteins.
    Verhoef LG; Lindsten K; Masucci MG; Dantuma NP
    Hum Mol Genet; 2002 Oct; 11(22):2689-700. PubMed ID: 12374759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.